Skip to content

Study of topical Unani drug Salikha and Honey with Benzoyl peroxide in Acne vulgaris

A Comparative Clinical Study of topical Unani formulation Salikha Honey with Benzoyl peroxide in Acne vulgaris A Randomized Open Label Study - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/12/098417
Enrollment
64
Registered
2025-12-03
Start date
Unknown
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L700- Acne vulgaris

Interventions

Intervention1: Salikha and Honey: Make a thin layer of paste and apply it on the affected area twice a day and then wash it off after 30 minutes Control Intervention1: Benzoyl Peroxide 5 percent: Appl

Sponsors

State Unani Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Participants aged 18 to 35 years of both genders Mild to moderate Acne vulgaris on the basis of GAGS Scale Global Acne Grading System Willing to give written informed consent and comply the study protocol

Exclusion criteria

Exclusion criteria: Pregnant and lactating women Patients having any severe systemic disease History of allergy to Honey and Salikha Individual with comorbid condition like acne rosacea nodulocystic acne acne fulminant acne necrotic psoriasis eczema erysipelas etc Patient using anti-androgenic drugs corticosteroid or anticonvulsant therapy or taking oral contraceptive pills within past weeks The participants will be excluded if they used oral acne treatment within 4 weeks topical treatment within 2 weeks or light laser therapy or oral treatment within 4 weeks Participants who had any other dermatologic diseases in the study area will not be eligible

Design outcomes

Primary

MeasureTime frame
Changes in Global Acne Grading System Timepoint: patients will be assessed on at baseline 15th day 30th day and 45th day

Secondary

MeasureTime frame
changes in cardiff acne disability index changes in physician global assessmentTimepoint: patients will be assessed on cardiff acne disability index and physician global assessment at baseline and 45th day

Countries

India

Contacts

Public Contactdr Mohd Khalid

State Unani Medical College and Hospital

khalidhameedkhan@gmail.com9916261251

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026